000 01277 a2200361 4500
005 20250517214659.0
264 0 _c20190131
008 201901s 0 0 fre d
022 _a0040-5957
024 7 _a10.1016/j.therap.2018.04.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGalaup, Ariane
245 0 0 _a[Attractiveness of France for international clinical research: 8th survey conducted by Leem (French association for pharmaceutical companies)].
_h[electronic resource]
260 _bTherapie
_cOct 2018
300 _a367-376 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBiomedical Research
650 0 4 _aClinical Trials as Topic
650 0 4 _aClinical Trials, Phase I as Topic
650 0 4 _aClinical Trials, Phase II as Topic
650 0 4 _aDrug Industry
650 0 4 _aFrance
650 0 4 _aHumans
650 0 4 _aPharmacology, Clinical
650 0 4 _aSurveys and Questionnaires
700 1 _aBarthélémy, Philippe
700 1 _aPouletty-Lefebvre, Brigitte
700 1 _aBéhier, Jehan-Michel
700 1 _aZetlaoui, Jean
700 1 _aBorel, Thomas
773 0 _tTherapie
_gvol. 73
_gno. 5
_gp. 367-376
856 4 0 _uhttps://doi.org/10.1016/j.therap.2018.04.002
_zAvailable from publisher's website
999 _c28383605
_d28383605